Will artificial intelligence chatbots replace clinical pharmacologists? An exploratory study in clinical practice

被引：17

作者：

Montastruc, Francois ^{[1
]}

Storck, Wilhelm ^{[1
]}

de Canecaude, Claire ^{[1
]}

Victor, Lea ^{[1
]}

Li, Julien ^{[1
]}

Cesbron, Candice ^{[1
]}

Zelmat, Yoann ^{[1
]}

Barus, Romain ^{[1
]}

机构：

[1] Toulouse Univ Hosp CHU, Fac Med, Ctr Pharmacovigilance & Pharmacoepidemiol, Dept Med & Clin Pharmacol, Toulouse, France

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2023年 / 79卷 / 10期

关键词：

ChatGPT; Drug information service; Safety; Pharmacovigilance; Adverse drug reaction;

D O I：

10.1007/s00228-023-03547-8

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

PurposeRecently, there has been a growing interest in using ChatGPT for various applications in Medicine. We evaluated the interest of OpenAI chatbot (GPT 4.0) for drug information activities at Toulouse Pharmacovigilance Center.MethodsBased on a series of 50 randomly selected questions sent to our pharmacovigilance center by healthcare professionals or patients, we compared the level of responses from the chatbot GPT 4.0 with those provided by specialists in pharmacovigilance.ResultsChatbot answers were globally not acceptable. Responses to inquiries regarding the assessment of drug causality were not consistently precise or clinically meaningful.ConclusionThe interest of chatbot assistance needs to be confirmed or rejected through further studies conducted in other pharmacovigilance centers.

引用

页码：1375 / 1384

页数：10

共 11 条

[1]

[Anonymous], Introducing ChatGPT.

[2] Comparing Physician and Artificial Intelligence Chatbot Responses to Patient Questions Posted to a Public Social Media Forum [J].